Alameda invests $40 million in Solana-based brokerage DeFi Oxygen
Alameda Research, a cryptocurrency trading company, has invested $40 million in Oxygen, DeFi, a Swiss-based brokerage company. MultiCoin, Genesis Capital and CMS also participated in the round. Oxygen will reportedly be launched in Serum, a decentralized ecosystem built on the Solana blockchain.
Sam Bankman-Fried, CEO of derivatives exchange FTX and advisor to Serum (SRM) and Oxygen (OXY), said that the high performance (approximately 50,000 transactions per second) and low transaction cost of the Solana blockchain (SOL) allow for more complex solutions than simple lending and borrowing instruments, which have proven to be some of DeFi's most successful projects to date, including primary brokerage.
